Breanna Krebs, the director of customer success at Apixio, joins us for the latest episode of RISE Radio, our podcast series that focuses on issues that impact our three communities: Quality & Revenue; Medicare Member Acquisition & Experience; and Social Determinants of Health.
In this 11-minute podcast, Krebs discusses the impact of the double sweeps occurring this July and next January related to the extension deadline for submitting risk adjustment data for use in the risk score calculation run that the Centers for Medicare & Medicaid Services (CMS) implemented due to the COVID-19 pandemic; what the end of the extension deadline means; potential challenges to the return of regular submission deadlines in a post-pandemic landscape; and best practices to stay ahead of these compressed deadlines and ensure the accuracy of your risk adjustment data submissions to CMS.
Deadlines for the 2023 sweeps of risk adjustment data are as follows:
About Breanna Krebs
Breanna Krebs oversees the relationships and supports the services delivered to Apixio’s clients. With over 20 years in health care, she has a strong understanding of the core components that drive customer success and uses this ability to work with external vendors and cross-functionally to ensure business deliverables and client needs are aligned. Prior to joining Apixio in 2015, Krebs was a vice president of development at Quirk Healthcare Solutions, where she created, trained, and mentored technical teams in India, Ukraine, Mexico, and the United States to provide development services and support for clients and internal software solutions for Quirk Healthcare. At Muir Medical Group IPA, she provided technical leadership to identify areas for system improvements and ensure projects met customer expectations and budget parameters. She holds a Bachelor of Arts degree in Sociology from the University of Oregon.
About Apixio
Apixio is advancing value-based care delivery with data-driven intelligence and analytics. Its AI-powered Apicare platform gives value-based care organizations across the health care spectrum the power to mine clinical information at scale, creating meaningful insights that will change the way health care is measured, care is delivered, and value is realized.